Ultra Pharma
Ultra Pharma / Intelligence & Analysis

Insights & Regulatory Intelligence

Critical analysis on Kenyan healthcare regulation, health technology assessment under SHA, and market access across East Africa.

Topics:All Articles (4)ReimbursementPolicyApprovalMarket entry
Featured Editorial
Reimbursement
Reimbursement6 min read

What the SHA benefits package means for a registered product

Coverage under the Social Health Authority flows through three funds. What that structure changes for a product that already holds Pharmacy and Poisons Board registration.

10 February 2026Read in-depth analysis

All Recent Analysis

Approval5 min read

What actually drives a PPB review timeline

Review duration is mostly a function of dossier quality and query handling. Where the time goes, and which parts an applicant controls.

4 December 2025Read analysis
Market entry7 min read

EAC harmonisation and the cost of the second market

The East African Community medicines regulatory harmonisation framework reduces duplication across member states. What still has to be rebuilt per market.

6 November 2025Read analysis